Design Therapeutics (DSGN) Enterprise Value (2020 - 2021)
Historic Enterprise Value for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to -$393.7 million.
- Design Therapeutics' Enterprise Value changed N/A to -$393.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$393.7 million, marking a year-over-year change of. This contributed to the annual value of -$36.1 million for FY2020, which is N/A changed from last year.
- According to the latest figures from Q3 2021, Design Therapeutics' Enterprise Value is -$393.7 million.
- Design Therapeutics' Enterprise Value's 5-year high stood at -$36.1 million during Q4 2020, with a 5-year trough of -$411.3 million in Q1 2021.